September 21, 2011,

Frontiers of the MIND focusing on Traumatic Brain Injury

Featuring Ann McKee, M.D. , Boston University

Dr. McKee’s research interests center on the neuropathological alterations of neurodegenerative diseases, with a primary focus on the role of tau protein, axonal injury, trauma, vascular injury, and neurodegeneration. Much of her current work centers on the long-term consequences of repetitive head injury from contact

Medications and Patients with Alzheimer’s Disease – What to Avoid

Gaby T. Thai, M.D.
Doctors are often asked whether there are any medications that someone with Alzheimer’s disease should avoid. Patients with Alzheimer’s disease may need medicines to treat symptoms of the disease, as well as for other health problems such as bladder incontinence, mood disturbances, high blood pressure, etc…  However, when a person takesmany medications, there is an increased risk of adverse effects, including confusion, mood swings, sleepiness, andworsening memory

Aging is an inevitable journey for everyone, and includes many obstacles and different paths to take.  How we live our lives can have enormous impact on whether we grow old gracefully, or succumb along the way. Good physical health, through diet and exercise, will allow people to remain active well into their twilight years, but as lifespan increases it is also important to take care of and maintain brain health as well.  Fortunately, it appears that what is good for

Researchers with the Institute for Memory Impairments and Neurological Disorders (UCI MIND) have discovered how a novel compound can reduce the accumulation of brain plaques seen in Alzheimer’s without the side effects produced by current drugs used for the chronic neurodegenerative disease. In a study published online in the Annals of Neurology, neurobiologists Kim Green and Frank LaFerla found that the ST101 compound triggers a process that carves up amyloid precursor proteins into benign molecules. These precursor proteins, when intact, ultimately can